viewGalan Lithium Ltd

Coffee with Samso - The brine lithium business is actually not a bad business

In this episode, Samso is intrigued by the lithium story and the role being played by Galan Lithium Ltd.

Galan Lithium Ltd - Coffee with Samso - The brine lithium business is actually not a bad business
Galan’s managing director Juan Pablo (JP) Vargas de la Vega chats to Samso

The brine lithium sector is something that I have never really looked at in detail.  I was a shareholder in one stock, but it was during the rising market, so I did not do too much research.

However, after talking to JP from Galan Lithium Ltd (ASX:GLN), I am very impressed with what they have to offer.

The whole sector is interesting. It is kind of like the iron ore industry in terms of the tonnage.

There is simply a heap of resource and the process of extracting the lithium is straight forward.

Having this Coffee with Samso with JP definitely was the highlight of all my sessions. I say this as I learned the most from this discussion.


The company’s projects are within the South American Lithium Triangle in the Hombre Muerto Basin, one of the most important and prolific salt flats in Argentina and indeed the world.

The basin is known to have the lowest impurity levels of any producing Salar in Argentina and has been in production for over 20 years.

Several areas are targeted within the project with the main focus being Candelas, in the south-east margin of the basin. Both areas have direct access to the salar including areas shallowly covered by recent alluvium.

At Candelas, the target is approximately a 15-kilometre-long deltaic channel, which is the main access channel for lithium charged waters from source rocks to the south of the basin.

The Candelas area adjoins Galaxy’s Sal de Vida project to the south.

Galan is aiming to estimate a maiden JORC resource as soon as practicable.

The company is also investigating the various processing options open to it, with a view towards maximising the potential to directly produce battery-grade lithium carbonate, the results of which will assist in the design and commissioning of a pilot plant.

Corporate information

Market Capitalisation: $25 million (July 2019)

Outstanding Shares: 129 million (July 2019)

Top 20 Shareholding %: 49% (July 2019)

Galan price chart

A special thank you goes out to David Tasker of Chapter One Advisors for lending me Jake Barker who took care of the videography and the bulk of the editing. It sure made life so much easier.


Samso is primarily a consulting company that delivers digital information to the market in terms of creating organic content.
Samso simplifies your story to customers or investors. Samso creates organic content for you to engage your audience and BRAND yourself to them.
Samso provides bespoke research and presentation for clients to engage their customers or investors.
Organic content allows audiences to feel a real sense of sincerity when you share your business strategy, allowing your business to stand out among the sea of social media traffic.
Working with Proactive allows exposing our insights to over 1.2 million monthly unique views internationally.
Samso has nearly 30 years of experience in developing business ideas and concepts in the Australasian region.
Samso has worked primarily in the mineral resources industry, capital markets and corporate finance. Noel Ong is the founder of Samso.

Quick facts: Galan Lithium Ltd

Price: 0.48 AUD

Market: ASX
Market Cap: $115.23 m

Add related topics to MyProactive

Create your account: sign up and get ahead on news and events


The Company is a publisher. You understand and agree that no content published on the Site constitutes a recommendation that any particular security, portfolio of securities, transaction, or investment strategy is...


Bionomics' positive pharmacokinetic results confirms it can begin second...

Bionomics Limited (ASX:BNO) (OTCQB:BNOEF) Executive Chairman Errol De Souza tells Proactive tells Proactive the Adelaide, Australia- based biopharmaceutical company has received positive pharmacokinetic results from a 7-day dosing study to treat PTSD, using its new formulation of BNC210. De...

1 day, 18 hours ago

3 min read